FCA Whistleblowers Accuse Gilead Of Defective-Drug Fraud
Gilead Sciences Inc. cheated taxpayers by selling contaminated and defective drugs to Medicare and Medicaid, whistleblowers charged in a False Claims Act lawsuit unsealed Wednesday in California federal court, adding to...To view the full article, register now.
Already a subscriber? Click here to view full article